RN with some diabetes education experience here. Some of the ultra lente insulins (degludec, glargine) are q 24h to q 36h dosing, which approaches the convenien

RN with some diabetes education experience here. Some of the ultra lente insulins (degludec, glargine) are q 24h to q 36h dosing, which approaches the convenience of an insulin pump (which are wildly expensive). Insulin pumps requires some maintenance but not as inconvenient as regular injections. This is not the kind of insulin that Walmart is announcing. What is going on is that big pharma is now charging a premium for the user experience, and not the actual cost of the product or amortizing R&D. (Of course the caveat here is that a therapy regimen that uses ultra lente insulins exclusively may be suitable for some type II diabetics who hadn’t achieved appropriate glucose control on oral antihyperglycemics, and that insulin dosing with meals using rapid acting insulin on top of a ultra slow acting insulin may follow after a while).